ZNHIT3 antibody
Principal name
ZNHIT3 antibody
Alternative names for ZNHIT3 antibody
TRIP3, Zinc finger HIT domain-containing protein 3, Thyroid receptor-interacting protein 3, Thyroid hormone receptor interactor 3, HNF-4a coactivator
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E)
Background of ZNHIT3 antibody
- Kit Component:
- - KN320125G1, Znhit3 gRNA vector 1 in pCas-Guide vector
- KN320125G2, Znhit3 gRNA vector 2 in pCas-Guide vector
- KN320125D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Olsen,J.V., (2006) Cell 127 (3), 635-648.
Human Placenta; WB Suggested Anti-ZNHIT3 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Placenta; ZNHIT3 antibody - N-terminal region (ARP50503_P050) in Human Placenta cells using Western Blot
ZNHIT3 monoclonal antibody (M09), clone 2F8. Western Blot analysis of ZNHIT3 expression in HepG2(Cat # L019V1 ).
WB Suggested Anti-ZNHIT3 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human Placenta
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP314666 | ZNHIT3 |
||||
| Purified recombinant protein of Homo sapiens zinc finger, HIT type 3 (ZNHIT3) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR220360L2V | Lenti ORF particles, Znhit3 (GFP-tagged) - Mouse zinc finger, HIT type 3 (Znhit3), 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR220360L1V | Lenti ORF particles, Znhit3 (Myc-DDK-tagged) - Mouse zinc finger, HIT type 3 (Znhit3), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||